New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
1
16

Harvard Apparatus Regenerative Technology, Connecticut Children’s Medical Center Collaborate to Develop Bioengineered Pediatric Esophageal Solutions

HOLLISTON, Mass., Aug 10, 2015 (BUSINESS WIRE) -- Harvard Apparatus Regenerative Technology, Inc., HART, +5.13% or HART, a biotechnology company developing bioengineered organs for life threatening conditions, has entered into an agreement with Connecticut Children’s Medical Center (Connecticut Children’s) on a pre-clinical collaboration to develop an innovative process for repairing or replacing the esophagus to treat life-threatening pediatric conditions such as esophageal atresia.  
marketwatch.com
over 6 years ago